Epidural steroid infiltration (ESI) and surgical decompression with or without fusion are established treatment options for symptomatic LSS. Results about efficiency of ESI are mixed. In some studies, a short-term benefit could be confirmed; however, most studies evaluating the long-term benefit did not show superior outcome compared with physical therapy. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] The long-term success of surgical treatment varies between 45% and 72%. 12 A lower selfrated preoperative health status, comorbidity, depression, and limited, preoperative walking ability were identified as strong predictors of an unfavorable clinical outcome. [12] [13] [14] In 2010 the LSS study was launched with the aim to identify indicators predicting the future course of patients with LSS. 15 It seems obvious that the quality of paravertebral musculature, which represents an important support of the spinal column, would affect the outcome of LSS treatment. Dohzono et al 16, 17 recently showed an association between paravertebral muscle degeneration and the amount of sagittal imbalance with low back pain (LBP). Furthermore, the paravertebral muscles are innervated by dorsal branches of the spinal nerve roots. A causal relation between nerve fiber compression as it occurs in spinal stenosis, and alteration of the paravertebral muscles is plausible. 18 In considering these aspects we raised the question whether muscle quality, as reflected by fatty degeneration of the lumbar paravertebral musculature, may affect the clinical outcome and failure rate of ESI or surgical decompression.
MATERIALS AND METHODS

Patient Selection and Treatment Strategies
The Swiss Lumbar Stenosis Outcome Study (LSOS), which is a prospective multicenter cohort study of patients with symptomatic degenerative LSS, was used as database (2010) (2011) (2012) (2013) (2014) (2015) . 15 The study was approved by the local ethical committee and conducted in accordance with the Declaration of Helsinki. All patients received written or oral information about the study and gave their written informed consent to participate. Patients with symptomatic LSS who received an ESI (group I, n ¼ 40) or lumbar decompression surgery (decompression, group II, n ¼ 165), who had a follow-up of at least 12 months and a pretreatment lumbar magnetic resonance imaging (MRI) were included (total n ¼ 205). Patients with evidence of stenosis caused by tumor, fracture, infection, or significant deformity or any previous spinal surgeries were not included into the cohort.
ESI was performed using contrast-enhanced fluoroscopy or computed tomography scan for guidance. Surgical decompression was performed with a standard open or microscopic posterior lumbar laminectomy or laminectomies. Fusion by pedicle screws with rods and intersomatic fusion and cage implantation were performed as revision for failed decompression surgery in cases of significant lumbar back pain or segmental instability.
Reinfiltration, surgery after infiltration, or revision surgery at the diseased segment was defined as treatment failure (Figure 1 ).
Image Analysis and Assessment of Paravertebral Muscle Quality
MRI was performed in all patients included in the Lumbar Stenosis Outcome Study. Because of the nature of a multicenter study, imaging was performed on different MRI scanners with field strengths at 1.5 and 3 T with varying scanning parameters. All imaging data from the participating clinical centers were collected at one place and therefore, saved on the picture archiving and communication system (IMPAX 6; AGFA Healthcare, Mortsel, Belgium) of the University hospital of city blinded for review process. 19 Two fellowship-trained musculoskeletal radiologists with 8 and 26 years of experience, who were blinded to clinical information and the results of the second reader, performed image analysis. Both radiologists had remote access to the picture archiving and communication system and worked independently from different cities. 19 Paravertebral muscle quality was determined at baseline and quantified by the degree of fatty degeneration on axial T2-weighted magnetic resonance images on the level L3 according to the Goutallier/Fuchs classification system 20, 21 : 0 ¼ normal, no fatty streaks, 1 ¼ some fatty streaks, 2 ¼ important fatty streaks, but still more muscle than fat, 3 ¼ as much fat as muscle, or 4 ¼ more fat than muscle. Example images for fatty atrophy are provided in Figure 2A -E. Intra-and inter-reader agreement for determining fatty degeneration was 0.87 and 0.45, respectively, and was reported in a former study by Winklhofer et al.
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Clinical Assessment
Clinical outcome was assessed at baseline and at 12 months using the Spinal Stenosis Measure (SSM), Numeric Rating Scale (NRS), Roland and Morris Disability Questionnaire (RMDQ), EQ-5D-3L sum score, and Cumulative Illness Rating Scale (CIRS). Data were in part interview administered and recorded by a study coordinator. All other questionnaires were self-administered and filled in by the patients themselves.
The SSM, an instrument specifically developed for spinal stenosis patients by Stucki et al 22 targets to measure severity of symptoms and quantifies disability of the LSS population. It was already used in different studies on LSS [23] [24] [25] [26] and consists of three different subscales: the symptom severity subscale, the physical function subscale, and the satisfaction subscale. The symptom severity scale can be divided into a pain domain (severity, frequency, and back pain) and a neuroischemic domain (leg pain, weakness, numbness, and balance disturbance). Score range is from 1 to 5 and 1 to 4 (best-worst).
The NRS serves for general assessment of LSS symptoms such as lower extremity pain and discomfort with a score range from 0 to 10 (best-worst).
The RMDQ is a back pain specific, self-rated physical disability questionnaire developed by Roland and Morris in 1983. 27 Disability is measured respective to the following categories: physical function activities and activities of daily living including eating and sleeping with a score range from 0 to 24 (best-worst).
The EQ-5D-3L is an assessment tool to measure healthrelated quality of life. It measures general nondiseasespecific health-related quality of life, including physical, mental, and social dimensions. 28 The health status measures five dimensions of health (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), which can be calculated as a sum score (score range 0-100, worst-best). 28 The second part of the questionnaire estimates patient's actual health status (score range 0-100, worst-best).
The CIRS documents the presence and severity of comorbid diseases in 14 organ systems (according to a modified version by Miller et al) 29 with a range from 0 to 56 (bestworst). The musculoskeletal organ system was separately included in the analysis.
Minimal Clinically Important Difference
The minimal clinically important difference (MCID) is defined as ''the smallest difference in a score that is considered to be worthwhile or important.'' 30 Thus, the MCID is a threshold for a relevant change in an outcome measure. Patients who reached or even exceed this threshold consider this change as meaningful and worthwhile. According to Stucki et al, 22 MCID for SSM is reached when ''Symptom Severity Scale'' improves at least 0.48 points and ''Physical Function Scale'' at least 0.52 points at follow-up.
The primary outcome of the study was defined as changes in SSM symptoms and function. Secondary outcomes included MCID in SSM symptoms and function, and changes in NRS, EQ-5D-3L, and RMDQ. Further secondary outcome was the need for reintervention (failure rate).
Statistical Analyses
All data were stored in a purpose-built database (Filemaker Pro 11, 2010; FileMaker Inc., Santa Clara, CA). Analysis of data consisted of descriptive statistics of patient demographics at baseline. Continuous variables were shown as mean and standard deviation, and categorical variables were shown as numbers and percentages of total, stratified by patients undergoing epidural infiltration (ESI, group I) or surgical treatment (group II), respectively. The nonparametric Wilcoxon test was used to compare changes in outcomes across Goutallier classification ( 1 /!2). To assess whether treatment failure was associated with the Goutallier classification, the chi-squared test was used. Logistic regression was used to model MCID in SSM symptoms and SSM function, depending on Goutallier classification, age, and treatment (surgical therapy vs. epidural infiltration). Results were presented as odds ratios (ORs) and confidence intervals (CIs).
The level of significance was set to a ¼ 0.05. All analyses were conducted with R for Windows (R Core Team [2014] . R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/).
RESULTS
In the present study, 205 patients were included; 40 patients were treated by ESI (group I), 165 patients underwent decompression surgery (group II, decompression surgery). Operated levels were mainly L4/5 (42%), L3/4 (35%), and L2/3 (13%), 109 patients (66%) underwent multilevel decompression. Baseline characteristics for age, sex, and CIRS are presented in Table 1 and were comparable in both groups.
In group I (ESI), 21 patients (52.5%) presented with good paravertebral muscle quality as defined by a Goutallier stage 1 or lower. Fatty degeneration stages of 2 or higher were found in 19 patients (47.5%). Reinfiltration or surgery after infiltration was necessary in 24 patients, which corresponds to a failure rate of 60%.
There was a tendency, though not significant, for the rate of re-intervention to be less in patients with bad muscle quality ( Figure 1 ). The corresponding P value of the chisquared test was 0.22.
In group II (decompression), 112 patients (67.9%) presented with good paravertebral muscle quality (Goutallier stage 1), whereas fatty degeneration stages !2 were observed in 53 patients (32.1%). Twenty-one patients underwent reinfiltration or revision surgery, which corresponds to a failure rate of 12.7%. There was no difference between patients with good or bad muscle quality (Figure 1 ). The corresponding P value of the chi-squared test was 0.81.
There was a tendency toward better clinical outcomes (SSM subscales, NRS, RMDQ, and EQ-5D-3L) in terms of improvement between baseline and 12 months follow-up in patients with Goutallier stage 1 or lesser as compared to Goutallier stage 2 or higher (Tables 2 and 3 ). These improvements, however, did not differ significantly, except for SSM symptoms (P ¼ 0.04) in group II.
Multiple logistic regression models were fitted to MCID in SSM symptoms and SSM function at 12 months. Results of the logistic regression models revealed that Goutallier stage 2 or higher was associated with significantly lower chances for MCID in SSM symptoms (OR ¼ 0.47, 95% CI 0.25-0.88, P ¼ 0.02). In the corresponding model for MCID in SSM function, the estimated OR was 0.85; however, the result was not statistically significant (P ¼ 0.61). Decompression surgery was associated with higher chances 
DISCUSSION
The results of our study indicate that relevant fatty degeneration of the paravertebral musculature (Goutallier stage !2), as a sign of low muscle quality, has low impact on failure rates and clinical outcome of treatments with ESI or decompression surgery. Surprisingly, Goutallier stage 2 or higher tended to have lower rate of reinterventions in infiltrated patients, even if not reaching statistical significance. On the contrary, in both groups, Goutallier stage 2 or higher was associated with less postoperative improvement in most clinical scores. These findings might be due to potential limitations of the study.
First, ESI addresses chemical pain mechanisms, which are independent of muscle quality. It is postulated that corticosteroids reduce inflammation either by inhibiting the synthesis or release of a number of proinflammatory substances or by causing a reversible local anesthetic effect. 31, 32 Modes of action of steroids include membrane stabilization, inhibition of neural peptide synthesis or action, blockade of phospholipase A 2 activity, prolonged suppression of ongoing neuronal discharge, and suppression of sensitization of dorsal horn neurons. 31, 32 Second, a follow-up of 1 year might be too short to find significant impact of fatty degeneration on clinical outcomes and a longer-term follow-up might reveal statistical significances in the here documented tendencies. A longer followup would, however, be challenged by the increasing crossover rate of conservatively treated to surgical treated patients over time. Third, the paravertebral muscle quality was measured only on the level L3. This disadvantage is mitigated by a study conducted by Dohzono et al 16 where in patients suffering from LSS no significant differences of fatty degeneration on different levels of the lumbar spine were observed. 16 Forth, spinopelvic parameters were not available for the evaluation of sagittal balance, which might be associated with lumbar back pain and could have introduced a bias. Bayerl et al 33 showed that sagittal balance did not influence the clinical outcome of patients with LSS 1 year after surgical decompression. Furthermore, it is well known that patients suffering from LSS lean forward to provide neural decompression by spinal canal widening in flexion. 34 Reactive improvement in the lumbar and global sagittal alignment can be induced by lumbar decompression surgery without fusion, even if sagittal imbalance exists preoperatively. 35 The low impact of muscle quality on clinical outcome as well as failure rate is surprising as different studies have demonstrated an association between paravertebral muscle degeneration and LBP. [36] [37] [38] Nevertheless our results are in concordance with the study of Kalichman et al, which evaluated different features of spinal degeneration and their association with selfreported LBP. The only degenerative feature associated with self-reported LBP was spinal stenosis. Other degenerative features such as intervertebral disc degeneration, facet joint osteoarthritis, spondylolysis, spondylolisthesis, and especially degeneration of the paravertebral muscles were not associated with the occurrence of LBP. 39 LBP is certainly not the only parameter determining the clinical outcome but is obviously represented in most questionnaires for clinical assessment of spinal pathologies. Furthermore the mean age of 75 years (ESI) and 73 years (decompression) may reduce the impact of musculature with respect to the general lower activity level, particularly strenuous activity.
Failure rate was lower in the surgical decompression group compared to the ESI group and decompression surgery was associated with higher chance of MCID in SSM function. This finding is consistent with previous studies showing no relevant long-term improvement with ESIs compared to physical therapy, 11, 40 and the long-term advantage of surgical decompression in selected patients. 41 
CONCLUSION
Relevant fatty degeneration of the paravertebral musculature, as a sign of low muscle quality, has low impact on clinical outcome and the high failure rates with conservative treatment by ESI compared to surgical decompression. Therefore fatty degeneration has no relevant prognostic value for LSS treatment.
Key Points
ESI and surgical decompression are established treatment options for symptomatic LSS. To our knowledge the impact of paravertebral muscle quality on clinical outcome and failure rates of ESI or surgical decompression in patients with symptomatic LSS has not been studied. With the here presented study we could show that relevant fatty degeneration of the paravertebral musculature has low impact on clinical outcome and the high failure rates with conservative treatment by ESI compared to surgical decompression. Therefore fatty degeneration has no relevant prognostic value for LSS treatment. 
